12/02/2025
Research is coming in strong for the benefits of GLP1s and this is outside of the already evident benefits of weight loss.
Let’s take a look, shall we…
Lower overall cancer risks - findings from JAMA Oncology indicate a reduction in 13 obesity-related cancers including breast, endometrial, and ovarian cancers.
Reduced risk of cardiovascular events - we know that the leading cause of death in women is cardiovascular disease and we know now that GLP1s help to reduce that risk. GLP1s have been shown to potentially improve risks associated with peripheral artery disease and lower the odds of major cardiovascular events.
Promise with patients struggling with infertility - a recent article from the NIH indicates promising research regarding PCOS and infertility. Women prescribed a GLP1 showed decreased rates of obesity, better insulin sensitivity, and many resumed ovulation.
Perimenopause possibilities - current and ongoing research shows promise in the reduction of perimenopausal symptoms.
We’re still seeing a lot of research coming down the pipeline, what excites you most?